{"id":"W2249358575","doi":"10.1200/jco.2006.24.18_suppl.5566","title":"A phase II study of lapatinib in recurrent or metastatic EGFR and/or ErbB2 expressing adenoid cystic (ACC) and non-ACC malignant tumors of the salivary glands (MSGT)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lapatinib; Internal medicine; Oncology; Chemotherapy; Adverse effect; Gastroenterology; Cancer; Breast cancer; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334782,0.001304202,0.001635687,0.0003314805,0.0003070875,0.00067393,0.0006428573,0.0008642322,0.0033688],"category_scores_gemma":[0.000738859,0.0005380766,0.0009550109,0.0003502621,0.0007117697,0.0005677265,0.0003589518,0.002248857,0.0006942109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005564807,"about_ca_system_score_gemma":0.001339738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008329453,"about_ca_topic_score_gemma":0.002117233,"domain_scores_codex":[0.9996538,0.000164535,0.00002049082,0.00005005975,0.00002686716,0.00008426722],"domain_scores_gemma":[0.9993389,0.0001043886,0.0001026357,0.0000525591,0.00003676008,0.0003645692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6969081,0.1161397,0.02092077,0.001118288,0.001094012,0.0008715002,0.0006048089,0.001935303,0.07279601,0.000338156,0.003290024,0.08398315],"study_design_scores_gemma":[0.4701884,0.5064994,0.01742337,0.0000256794,0.0002530635,0.0005759517,0.000079221,0.0008355831,0.002482544,0.0001113074,0.001506648,0.00001886591],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956137,0.000908478,0.0002683366,0.0001544767,0.00004923542,0.001913102,0.0003763203,0.00002974132,0.000686507],"genre_scores_gemma":[0.9910124,0.001152957,0.001177418,0.0004804781,0.0001190022,0.002617928,0.001536272,0.00001529855,0.001888145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0033688,"threshold_uncertainty_score":0.01126975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09390375300937577,"score_gpt":0.4973413336384716,"score_spread":0.4034375806290958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}